X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (499) 499
cardiac & cardiovascular systems (488) 488
female (333) 333
male (328) 328
index medicus (289) 289
middle aged (287) 287
aged (232) 232
treatment outcome (149) 149
stents (133) 133
coronary angiography (132) 132
time factors (110) 110
prospective studies (103) 103
cardiology (100) 100
percutaneous coronary intervention (94) 94
drug-eluting stents (89) 89
cardiovascular (87) 87
risk factors (81) 81
angioplasty (80) 80
follow-up studies (79) 79
peripheral vascular disease (74) 74
adult (71) 71
follow-up (71) 71
implantation (71) 71
thrombosis (69) 69
abridged index medicus (67) 67
revascularization (66) 66
cardiology and cardiovascular medicine (65) 65
fractional flow reserve (65) 65
coronary artery disease (64) 64
stent (64) 64
coronary disease - therapy (62) 62
coronary artery disease - therapy (61) 61
coronary vessels (61) 61
heart attacks (61) 61
angiography (57) 57
restenosis (57) 57
artery-disease (56) 56
intervention (55) 55
transluminal angioplasty (52) 52
angioplasty, balloon, coronary (51) 51
severity of illness index (50) 50
acute myocardial-infarction (49) 49
care and treatment (49) 49
risk assessment (49) 49
predictive value of tests (48) 48
cardiac patients (47) 47
europe (47) 47
disease (46) 46
hematology (46) 46
prognosis (46) 46
cardiovascular disease (45) 45
coronary disease - diagnostic imaging (45) 45
intravascular ultrasound (43) 43
outcomes (43) 43
bare-metal stents (42) 42
coronary circulation (42) 42
mortality (42) 42
myocardial infarction (41) 41
coronary heart disease (40) 40
myocardial-infarction (40) 40
atherosclerosis (39) 39
coronary artery disease - diagnostic imaging (39) 39
platelet aggregation inhibitors - therapeutic use (39) 39
prosthesis design (39) 39
sirolimus - analogs & derivatives (39) 39
sirolimus - administration & dosage (38) 38
coronary artery bypass (37) 37
optical coherence tomography (37) 37
coronary stenosis - therapy (36) 36
guidelines (36) 36
recurrence (36) 36
coronary angiography - methods (35) 35
coronary restenosis - prevention & control (35) 35
myocardial infarction - therapy (35) 35
myocardial revascularization (35) 35
coronary stenosis - diagnostic imaging (34) 34
coronary vessels - diagnostic imaging (34) 34
stenosis (34) 34
medicin och hälsovetenskap (33) 33
echocardiography (32) 32
electrocardiography (32) 32
medical and health sciences (32) 32
angioplasty, balloon, coronary - methods (31) 31
coronary artery disease - diagnosis (31) 31
coronary-artery-disease (31) 31
risk (31) 31
stable angina (31) 31
analysis (30) 30
angioplasty, balloon, coronary - adverse effects (30) 30
cardiac catheterization (30) 30
lesions (30) 30
trial (30) 30
aged, 80 and over (29) 29
angina pectoris (29) 29
angioplasty, balloon, coronary - instrumentation (29) 29
coronary stenosis - physiopathology (29) 29
myocardial infarction - etiology (29) 29
percutaneous coronary intervention - adverse effects (29) 29
coronary vessels - physiopathology (28) 28
patients (28) 28
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (914) 914
Spanish (14) 14
French (11) 11
Italian (6) 6
Polish (5) 5
Portuguese (3) 3
Dutch (2) 2
Czech (1) 1
German (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9908, pp. 1879 - 1888
Journal Article
Journal Article
by Thygesen, Kristian and Alpert, Joseph S and Jaffe, Allan S and Simoons, Maarten L and Chaitman, Bernard R and White, Harvey D and Katus, Hugo A and Apple, Fred S and Lindahl, Bertil and Morrow, David A and Clemmensen, Peter M and Johanson, Per and Hod, Hanoch and Underwood, Richard and Bax, Jeroen J and Bonow, Robert O and Pinto, Fausto and Gibbons, Raymond J and Fox, Keith A and Atar, Dan and Kristin Newby, L and Galvani, Marcello and Hamm, Christian W and Uretsky, Barry F and Gabriel Steg, Ph and Wijns, William and Bassand, Jean-Pierre and Menasché, Phillippe and Ravkilde, Jan and Magnus Ohman, E and Antman, Elliott M and Wallentin, Lars C and Armstrong, Paul W and Januzzi, James L and Nieminen, Markku S and Gheorghiade, Mihai and Filippatos, Gerasimos and Luepker, Russell V and Fortmann, Stephen P and Rosamond, Wayne D and Levy, Dan and Wood, David and Smith, Sidney C and Hu, Dayi and Lopez-Sendon, José-Luis and Robertson, Rose Marie and Weaver, Douglas and Tendera, Michal and Bove, Alfred A and Parkhomenko, Alexander N and Vasilieva, Elena J and Mendis, Shanti and Baumgartner, Helmut and Ceconi, Claudio and Dean, Veronica and Deaton, Christi and Fagard, Robert and Funck-Brentano, Christian and Hasdai, David and Hoes, Arno and Kirchhof, Paulus and Knuuti, Juhani and Kolh, Philippe and McDonagh, Theresa and Moulin, Cyril and Popescu, Bogdan A and Reiner, Željko and Sechtem, Udo and Sirnes, Per Anton and Torbicki, Adam and Vahanian, Alec and Windecker, Stephan and Morais, Joao and Aguiar, Carlos and Almahmeed, Wael and Arnar, David O and Barili, Fabio and Bloch, Kenneth D and Bolger, Ann F and Botker, Hans Erik and Bozkurt, Biykem and Bugiardini, Raffaele and Cannon, Christopher and De Lemos, James and Eberli, Franz R and Escobar, Edgardo and Hlatky, Mark and James, Stefan and Kern, Karl B and Moliterno, David J and Mueller, Christian and Neskovic, Aleksandar N and Pieske, Burkert Mathias and Schulman, Steven P and Storey, Robert F and Taubert, Kathryn A and Vranckx, Pascal and Wagner, Daniel R and Joint ESC ACCF AHA WHF Task Force and ESC Committee for Practice Guidelines (CPG) and Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction and Classification Subcommittee and Heart Failure Subcommittee and Authors/Task Force Members Chairpersons and ECG Subcommittee and Imaging Subcommittee and Trials & Registries Subcommittee and Biomarker Subcommittee and Intervention Subcommittee and Global Perspective Subcommittee and the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction and Epidemiology Subcommittee and Document Reviewers and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala universitet and Institutionen för medicinska vetenskaper and Uppsala kliniska forskningscentrum (UCR)
European Heart Journal, ISSN 0195-668X, 10/2012, Volume 33, Issue 20, pp. 2551 - 2567
Journal Article